15 May 2002
The impact of very late revascularization of occluded infarct-related artery on cardiac mortality and the incidence of sudden death in survivors of acute myocardial infarction -long-term observation.
Maciej Kośmider, Ryszard Jaszewski, Paweł Ptaszyński, Halina Bolińska, Jan Ruta, Krzysztof Jerzy Wranicz, Marcin Rosiak, Janusz ZasłonkaMed Sci Monit 2002; 8(5): CR364-370 :: ID: 420835
Abstract
BACKGROUND: In survivors of acute myocardial infarction (AMI), an occludedinfarct-related artery (IRA) is an important predictor of cardiac death (CD) and sudden death (SD). Earlyreperfusion of the IRA was associated with improved survival rate. The purpose of the present study wasto assess if late IRA revascularization, performed 10-30 days after AMI, also has a beneficial effecton the incidence of CD and SD during an 18-month follow-up. MATERIAL/METHODS: The study population consistedof 93 post-MI patients with occluded IRA on coronary angiography. The patients were divided into 2 groupsaccording to IRA status at discharge -- revascularized (47 patients) or occluded (46 patients) -- andfollowed. Before revascularization, the two groups of patients did not differ in the prevalence of clinicaland angiographic variables, or in the incidence of risk factors for SD. In patients who underwent angioplastyor bypass graft surgery of closed IRA, the markers of electrical instability demonstrated no significantimprovement after revascularization. RESULTS: During the 18-month follow-up a significantly lower incidenceof CD (0% vs 15%, p<0.01) and SD (0% vs 11%, p<0.03) was observed in the group of patients with revascularized IRA than in the group of patients with occluded IRA.
Conclusions: In survivors of AMI, late reperfusion of occluded IRA is associated with reduced 18-month cardiac mortality. The beneficial effect of this procedure on the incidence of sudden death, not associated with improvement in myocardial electrical stability, suggests that ischemia can be considered an important factor modulating the arrhythmogenic substrate.
Keywords: Angioplasty, Transluminal, Percutaneous Coronary, Coronary Artery Bypass, Death, Sudden, Follow-Up Studies, Risk Factors, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952